Mostly True
Korean industry performance in the current downturn shows a split picture: semiconductor operations remain weak, while the bio and battery businesses have continued to perform steadily, cushioning the overall impact on the companies concerned.
The semiconductor segment, long the primary earnings driver for Korea's largest tech companies, has been in a slump that has weighed on overall business results. Weak conditions in the chip business have dragged down performance at companies such as Samsung Electronics and SK hynix, which are heavily exposed to memory and foundry cycles.
By contrast, the bio and battery businesses have held up well during the same period. Their steady performance has helped offset part of the semiconductor weakness, giving the conglomerates a more balanced earnings structure than during past chip downturns.
The overall outcome is one of divergence: a struggling core chip business alongside resilient non-semiconductor segments. The claim that bio and battery units are faring well despite the semiconductor slump is largely supported by the facts, though the degree of the offset has not been precisely quantified.
Taken together, the assertion that bio and battery businesses are performing well amid the semiconductor downturn stands up in most respects — the claim is Mostly True.